STADA Pymepharco

About STADA Pymepharco

STADA Pymepharco has been the sole wholly-owned affiliate of STADA Group (Germany) in Vietnam since 2021. As one of the leading pharmaceutical manufacturers in Vietnam, STADA Pymepharco is committed to delivering internationally recognized, high-quality medicines at affordable prices. Two EU-GMP-certified manufacturing sites in Tuy Hoa and Dak Lak (formerly Phu Yen province) have an annual production capacity of 1.2 billion units per site, plus an additional 20–40 million finished packs per site annually. The company has 25,000 SKUs globally, including 8,000 Consumer Healthcare (CHC) products – built on a foundation of approximately 800 Active Pharmaceutical Ingredients (APIs). In Vietnam, there are 400 SKUs, including 250 Generics (Rx) and 150 CHC products, with around 80 assessed as bioequivalent to innovator medicines. STADA Pymepharco is trusted by over 14,000 customers and partners, including hospitals, pharmacies, retail chains, and other pharmaceutical businesses. Based on our purpose “Caring for People’s Health as a Trusted Partner”, our aim is to provide “German standard” healthcare in Vietnam and to the world.